Showing 1 posts of 1 posts found.
AstraZeneca is embarking upon a joint venture that will involve the building of a new $125 million small-molecule plant in …
InnoScot highlights NHS Scotland’s progress towards net zero healthcare
NHS England approves delayed-release treatment for rare kidney disease
Product value to pathway impact: What the CVD Modern Service Framework means for pharma
Functional lung imaging offers new possibilities for respiratory care
Five Facts about cardiovascular disease